Galaxy Diagnostics

“You’re fine.” “Your tests are normal.”

When it comes to Lyme and tick-borne disease, these statements often reflect the limits of current testing methods – not the full clinical picture.

The challenge is that standard tests use indirect testing methods, meaning they rely on detecting the body’s immune response. But, in early stages, that response may not yet be measurable.

In fact some estimates – including data from Bay Area Lyme Foundation – suggest that up to 64–78% of early Lyme cases may go undetected using standard approaches.

So, what does that tell us? It tells us that a lot of cases are potentially being missed.

Swipe for three key signs that testing may not be telling the full story.